North Capital’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$412K Sell
2,903
-54
-2% -$7.46K 0.29% 50
2026
Q2
$380K Buy
2,957
+37
+1% +$4.33K 0.29% 61
2026
Q1
$351K Buy
2,920
+10
+0.3% +$1.15K 0.3% 55
2025
Q4
$306K Sell
2,910
-82
-3% -$7.7K 0.26% 60
2025
Q3
$251K Buy
2,992
+1
+0% +$82 0.19% 64
2025
Q2
$237K Sell
2,991
-117
-4% -$9.3K 0.2% 63
2025
Q1
$279K Buy
+3,108
New +$290K 0.26% 55

Other funds holding MRK

North Capital's MRK Position: Q3 2026 in Review

North Capital reduced its Merck (MRK) stake by 1.8% in Q3 2026, selling an estimated $7.46K and leaving 2,903 shares worth $412K. The position accounts for 0.29% of the portfolio, ranked #50.

North Capital first reported a position in MRK in Q1 2025 and has held it in 7 quarters since. 1,705 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • North Capital held 2,903 shares of Merck worth $412K as of Q3 2026.
  • North Capital sold 54 Merck shares in Q3 2026, an estimated $7.46K.
  • Merck made up 0.29% of North Capital's portfolio in Q3 2026, its #50 holding.
  • North Capital first reported a position in Merck in Q1 2025 and has held it in 7 quarters since.
  • 1,705 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on North Capital's 13F filing for Q3 2026, filed 16 Oct 2026.